Safety and Immunogenicity of the ChAdOx1–MVA-vectored Conserved Mosaic HIVconsvX Candidate T-cell Vaccines in HIV-CORE 005.2, an Open-Label, Dose-Escalation, First-in-human, Phase 1 Trial in Adults Living Without HIV-1 in the UK
The Lancet Microbe(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要